Dramatic regression of cutaneous, nodal, and visceral melanoma metastases

J Am Acad Dermatol. 2011 Sep;65(3):665-666. doi: 10.1016/j.jaad.2010.06.006.

Authors

Diona L Damian¹, Robyn P M Saw²

Affiliations

¹ Department of Dermatology, University of Sydney, Australia; Sydney Cancer Centre, Royal Prince Alfred Hospital, Australia; Melanoma Institute Australia, North Sydney, Australia. Electronic address: diona.damian@sswahs.nsw.gov.au.
² Discipline of Surgery, University of Sydney, Australia; Sydney Cancer Centre, Royal Prince Alfred Hospital, Australia; Melanoma Institute Australia, North Sydney, Australia.

PMID: 21839330
DOI: 10.1016/j.jaad.2010.06.006

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adjuvants, Immunologic / administration & dosage
Aged, 80 and over
Anti-Infective Agents, Local / administration & dosage
Cyclopropanes / administration & dosage*
Humans
Immunotherapy*
Lung Neoplasms / secondary*
Lymphatic Metastasis
Male
Melanoma / drug therapy*
Melanoma / secondary
Silver Sulfadiazine
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology*

Substances

Adjuvants, Immunologic
Anti-Infective Agents, Local
Cyclopropanes
diphenylcyclopropenone
Silver Sulfadiazine